Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.9 CHF | -4.08% | -1.20% | -34.07% |
Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.07% | 214M | |
+2.56% | 42.75B | |
+47.70% | 41.61B | |
+11.90% | 41.34B | |
-8.83% | 26.59B | |
+7.11% | 25.49B | |
-22.80% | 18.12B | |
+30.52% | 12.24B | |
-1.92% | 11.76B | |
+9.32% | 11B |
- Stock Market
- Equities
- XLS Stock
- News Xlife Sciences AG
- Xlife Sciences' Portfolio Company Wins US Patent for Active Ingredient of Inflammatory Pain Drug